Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1W01
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,365
Award facts
- Contract value 100% obligated
- $24,364.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,364.50 to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 mg tablets (30-count units) with a firm fixed-price structure. This non-set-aside award was issued on January 20, 2026, with an ultimate completion date of January 21, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2031.
XELJANZ XR is a branded immunosuppressive medication used in the treatment of rheumatoid arthritis and other inflammatory conditions, making this award part of DLA's broader medical supply chain supporting military healthcare programs globally. AmerisourceBergen's role as a pharmaceutical distributor enables it to fulfill federal procurement requirements across multiple therapeutic domains, including specialty medications and brand-name drugs essential to military treatment facilities and veterans' healthcare systems. The competitive award reflects the contractor's established capability to meet federal pharmaceutical supply specifications and delivery timelines through the DLA's open contracting processes.
Quick answers
Who was awarded contract SPE2DR26F1W01?
SPE2DR26F1W01 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F1W01 worth?
The government has obligated $24,365 on SPE2DR26F1W01.
Is contract SPE2DR26F1W01 an order under another contract?
Yes. SPE2DR26F1W01 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1W01 competed?
The extent of competition for SPE2DR26F1W01 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award